Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Kangmei Pharma to Raise $529 Million

publication date: Dec 29, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Kangmei Pharmaceutical will raise up to 3.5 billion RMB ($529 million) by offering rights for new shares to existing shareholders. The company will offer three new shares for each ten shares held at a price of 6.88 RMB each, a total of 508 million new shares. The company’s stock is currently selling for 20.99 RMB. More details....

Stock Symbol: (SHEX: 600518)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors